These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18583964)

  • 21. Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
    Carlisle SM; Hein DW
    Int J Oncol; 2018 Aug; 53(2):694-702. PubMed ID: 29901116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers.
    Willis S; Hutchins AM; Hammet F; Ciciulla J; Soo WK; White D; van der Spek P; Henderson MA; Gish K; Venter DJ; Armes JE
    Genes Chromosomes Cancer; 2003 Apr; 36(4):382-92. PubMed ID: 12619162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer.
    Soysal SD; Kilic IB; Regenbrecht CR; Schneider S; Muenst S; Kilic N; Güth U; Dietel M; Terracciano LM; Kilic E
    Breast Cancer Res Treat; 2015 Jun; 151(3):709-15. PubMed ID: 25981900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.
    Moelans CB; Holst F; Hellwinkel O; Simon R; van Diest PJ
    PLoS One; 2013; 8(12):e84189. PubMed ID: 24367641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it time to ReSET the standard for estrogen receptor testing in breast cancer?
    Oesterreich S; Lee AV; Davidson NE
    J Clin Oncol; 2010 Sep; 28(27):4101-3. PubMed ID: 20697070
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of Gene Amplification by Multiplex Ligation-Dependent Probe Amplification in Comparison with In Situ Hybridization and Immunohistochemistry.
    Tabarestani S; Ghaderian SM; Rezvani H
    Asian Pac J Cancer Prev; 2015; 16(17):7997-8002. PubMed ID: 26625832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of ESR1 amplification in a series of breast cancers.
    Adélaïde J; Finetti P; Charafe-Jauffret E; Wicinski J; Jacquemier J; Sotiriou C; Bertucci F; Birnbaum D; Chaffanet M
    Int J Cancer; 2008 Dec; 123(12):2970-2. PubMed ID: 18816632
    [No Abstract]   [Full Text] [Related]  

  • 28. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
    Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.
    Tozlu-Kara S; Roux V; Andrieu C; Vendrell J; Vacher S; Lazar V; Spyratos F; Tubiana-Hulin M; Cohen P; Dessen P; Lidereau R; Bièche I
    J Mol Endocrinol; 2007 Oct; 39(4):305-18. PubMed ID: 17909269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of DNA amplification on gene expression patterns in breast cancer.
    Hyman E; Kauraniemi P; Hautaniemi S; Wolf M; Mousses S; Rozenblum E; Ringnér M; Sauter G; Monni O; Elkahloun A; Kallioniemi OP; Kallioniemi A
    Cancer Res; 2002 Nov; 62(21):6240-5. PubMed ID: 12414653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
    Chin SF; Teschendorff AE; Marioni JC; Wang Y; Barbosa-Morais NL; Thorne NP; Costa JL; Pinder SE; van de Wiel MA; Green AR; Ellis IO; Porter PL; Tavaré S; Brenton JD; Ylstra B; Caldas C
    Genome Biol; 2007; 8(10):R215. PubMed ID: 17925008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiling of lung cancer based on suppression subtraction hybridization (SSH).
    Petersen S; Petersen I
    Methods Mol Med; 2003; 75():189-207. PubMed ID: 12407742
    [No Abstract]   [Full Text] [Related]  

  • 34. Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.
    Ryan N; Chorley B; Tice RR; Judson R; Corton JC
    Toxicol Sci; 2016 May; 151(1):88-103. PubMed ID: 26865669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
    Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
    Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
    Dressman MA; Baras A; Malinowski R; Alvis LB; Kwon I; Walz TM; Polymeropoulos MH
    Cancer Res; 2003 May; 63(9):2194-9. PubMed ID: 12727839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
    Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
    Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling predicts outcome in breast cancer.
    van 't Veer LJ; Dai H; van de Vijver MJ; He YD; Hart AA; Bernards R; Friend SH
    Breast Cancer Res; 2003; 5(1):57-8. PubMed ID: 12559048
    [No Abstract]   [Full Text] [Related]  

  • 40. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.